Issuu on Google+

I

Anti-Infective Pharmaceuticals Market - India September 2011


Executive Summary Market

Anti-infective pharmaceuticals market in India is valued at INR X bn in 20-Market is expected to grow at a CAGR of x% from 20---Anti infectives are the largest contributor to domestic sales, contributing around y%

Drivers: Drivers and Challenges

Challenges:

Increasing patient population Increasing number of vaccine approvals Increase in health insurances

Pricing pressure Logistic problems in the vaccine market

Introduction of new drugs

Drug regulation and patents

Competition

Strategic recommendations

Phases of clinical trial Approval and licensing of drugs Patents Highly fragmented market with large number of players Major foreign players in the market include Gilead inc, Abbott, Glaxosmithkline etc Major domestic companies include Ranbaxy, Cipla, Dr. Reddy’s, Sun Pharmaceuticals, Panacea Biotech, Torrent Pharmaceuticals among others Foray into the adult vaccine market Partnership with Governmental and private bodies

ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT

2


•Introduction •Market Overview •Drivers & Challenges •Government Initiatives •Drug Regulation and Patents •Competition •Strategic Recommendations

ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT

3


Indian anti-infectives market is expected to witness an enormous growth over the coming years Indian Market - Overview •Anti-infectives belong to the acute segment which makes up around z% of the total pharmaceutical industry Anti-infectives are the largest contributor to domestic pharmaceuticals sales, contributing around y%

Market Size and Growth INR bn 200 x%

150 100

Cephalosporins, penicillins and quinolones are key drug classes among anti-infectives, with a share of around z% of the country’s anti-infectives market

• Presently the market has a size of INR X bn, and is expected to grow at a CAGR of x% from 20----• In 2010 GSK’s Augmentin was the highest selling drug with sales of INR Y bn Zifi, Taxim ,Monocef, Mox, Taxim-O , Zinacef and Gerimac were the other top selling drugs

• India has emerged as one of the leading vaccine manufacturer in recent times, producing z% of the global health vaccines Pentaxim, Varivax and Prevenar were the top selling vaccines in 20--

x3 x2

x1

x4

x6

x5

50 2010

2011e

0 2012e

2013e

2014e

2015e

Top pharmaceutical segments - 2010 0

2

4

6

8

10

12

14

18 %

anti-infectives

1 y2

CVS gastro CNS

y

y

3

respiratory

yy4

diabetes pain oncology

16

5 y6 y8

y7

Source: ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT

4


Drivers & Challenges - Summary

Drivers

Challenges

Increasing patient population

Pricing pressure

Increasing number of vaccine approvals

Logistic problems in the vaccine market

Increase in health insurances Introduction of new drugs

ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT

5


Government Initiatives - Summary

Changes in tax structure

Control programmes

Government Initiatives

PPP Projects

Reduction in drug prices

ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT

6


Major domestic players in the market (1/9) Company Snapshot: Company 1 Corporate Information Headquarters

Location A

Founded

19--

Products Key People

Financial Performance Revenue INR bn

Revenue INR bn Profit / Loss 100 r1

Product 1, product 2

r2

Profit r4 r3

60 40

50

20

Person X- MD

0 2008

0 2009

2010

2011

Business Highlights • Employing around XX people, Company 1 is India’s largest pharmaceutical company, having manufacturing facilities in seven countries and serving customers in over YY countries • In June 20--, the company entered into an alliance with Company X to create an innovator and generic pharmaceuticals powerhouse • Company 1 launched anti-infectives such as Product 1 and Product 2 for the first time in India and is trying to promote the concept of product 3 on a local basis •Signed an agreement with Company X for manufacturing and marketing 3 new HIV/AIDS drugs in India and developing countries • Has been working on an anti-malaria research project since May 20-- to develop cheap anti malarial drugs Source: ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT

7


For more detailed information kindly visit:

http://www.bharatbook.com/healthcare-market-research-reports/anti-infectiv

Bharat Book Bureau Phone : +91 22 27810772, 27810773 Fax : +91 22 27812290 E-mail : info@bharatbook.com Website : www.bharatbook.com


Anti-Infective Pharmaceuticals Market in India 2012